Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05158452 · ClinicalTrials.gov registry record
Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 8
- Enrollment target
NCT05158452: Completed study, sponsored by Ohio State University Comprehensive Cancer Center.
NCT05158452 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 8 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05158452 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and polygenic test results, obtain information about patients' questions/ concerns about test results to use in post-genetic test counseling, and determine patient preference (e.g. telephone) for receipt of post-genetic test counseling.
Interventions
- PROCEDURE Discussion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2020-12-09 |
| Est. Completion | 2022-10-30 |
What the finished NCT05158452 record still lists
NCT05158452 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 8 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Discussion is the first listed.
NCT05158452 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05158452 about?
NCT05158452 is a clinical study titled "Development of a Genetic Counseling Patient Preference Intervention for Women at Elevated Risk for Breast Cancer". This study develops a genetic counseling patient preference intervention for women at elevated risk for breast cancer. This study aims to develop an intervention that may deliver educational videos about breast cancer, heredity, multigene tests results and polygenic risk score, provide multigene and...
What is the current status of trial NCT05158452?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2020-12-09. Estimated completion is 2022-10-30.
What interventions are being tested in trial NCT05158452?
The interventions under investigation include: Discussion (PROCEDURE).
Who is sponsoring clinical trial NCT05158452?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI